Analysis of the Clinical Efficacy and Safety of Chinese Herbal Decoction Pieces Combined With Granules in the Treatment of Essential Hypertension Based on Chinese Herbal Formulas
Guo Weiwei1, Yang Li2, Yao Gang3
1. Department of Pharmacy,Zhengyang County People's Hospital,Zhumadian 463600,China; 2. Department of Cardiology,Zhumadian Central Hospital,Zhumadian 463600,China; 3. TCM Pharmacy,Zhengyang County People's Hospital,Zhumadian 463600,China
Abstract：Objective To explore the clinical efficacy and safety of Chinese herbal decoction pieces combined with granules in the treatment of essential hypertension based on Chinese herbal formulas.Methods In this study,subjects with essential hypertension were selected and randomly divided into two groups,each with an equal number of 66 cases.The control group was given Chinese medicine decoction pieces,and the observation group was given Chinese medicine granules combined treatment.The efficacy of the two groups of patients was compared;the scores of TCM symptoms,blood pressure and adverse reactions during the treatment of the two groups were recorded;the compliance of the two groups of patients before and after the treatment was observed;the two groups of patients were followed up for one year,and the two groups of patients had adverse events The cumulative incidence was recorded.Results After treatment,by comparing the two groups of TCM symptom scores,it was found that the scores of the two groups were reduced,and the scores of the observation group were lower than those of the control group,but the difference between the two was not significant（P>0.05）;After treatment,both the medication compliance and the total effective rate of the two groups of patients were significantly increased,and the compliance and effective rate of the observation group were significantly better than those of the control group（P<0.05）;Comparing the blood pressure of the two groups,it was found that both systolic and diastolic blood pressures decreased in the two groups,and the decrease in the observation group was more significant（P<0.05）;One-year follow-up found that 5 cases（7.58%）in the observation group had adverse events;13 cases（19.70%）in the control group had adverse events,the difference was statistically significant（P<0.05）.Conclusion For patients with essential hypertension,the clinical efficacy of the treatment of Chinese herbal medicine and the combination of Chinese medicine granules is equivalent,but the blood pressure improvement effect of the combined granules treatment is more significant.In addition,it can improve compliance and has a higher clinical application value.
郭炜炜, 杨丽, 姚刚. 基于中药配方下中药饮片联合颗粒治疗原发性高血压的临床疗效和安全性分析[J]. 哈尔滨医药, 2023, 43(1): 109-112.
Guo Weiwei, Yang Li, Yao Gang. Analysis of the Clinical Efficacy and Safety of Chinese Herbal Decoction Pieces Combined With Granules in the Treatment of Essential Hypertension Based on Chinese Herbal Formulas. journal1, 2023, 43(1): 109-112.
[1] Kang M G,Kim K I,Ihm S H,et al.Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension(Fimasartan in the Senior Subjects(FITNESS)):study protocol for a randomized controlled trial[J].Trials,2019,20(1):389. [2] Gates P.Arteriosclerosis with superimposed atherosclerosis is the cause not the consequence of essential hypertension[J].Medical Hypotheses,2020,144(1):110236. [3] 赵倩倩,李媛媛,陈聪,等.中医药治疗原发性高血压的作用机制研究现状与展望[J].中华中医药杂志,2020,35(4):3. [4] 李金华,周加林.配方颗粒与传统饮片汤剂治疗1~2级高血压的降压疗效[J].中西医结合心血管病电子杂志,2017,5(1):2. [5] 杨建忠,乔志宏.中药免煎颗粒与中药饮片的临床使用效果对比研究[J].检验医学与临床,2019,16(S2):3. [6] 《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治,2019,19(1):44. [7] 郑筱萸. 中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002. [8] 徐迪华,徐剑秋.中医量化诊断[M].江苏:江苏科学技术出版社,1997. [9] 陈景辉. 华佗再造丸治疗脑梗塞恢复期的临床观察[D].湖北:湖北中医药大学,2010. [10] 杨蕾,屠燕,滕中华,等.高血压治疗依从性促进与障碍量表汉化及信效度检验[J].护理研究,2019,33(7):4. [11] Jun-Won L,Eunhee C,Jung-Woo S,et al.Comparison of blood pressure variability between losartan and amlodipine in essential hypertension(COMPAS-BPV)[J].American Journal of Hypertension,2020,12(8):8. [12] 孟志刚,张晓鹰.八味降压汤配方颗粒治疗轻中度高血压病的疗效及对血液流变学的影响[J].中西医结合心脑血管病杂志,2015,13(4):2. [13] 邢冬梅,刘新灿,张俊华,等.中医药防治高血压病及其并发症的问题与解决策略[J].中华中医药杂志,2020,35(1):3. [14] 李蜜,靳利利.中医从肝辨证治疗女性更年期高血压病的临床疗效观察[J].广州中医药大学学报,2019,36(4):5. [15] 周晓君,郑京胜.我院传统中药饮片与中药配方颗粒的使用情况调查[J].中医药管理杂志,2020,28(17):29-30. [16] 杨洋,王志强,任丽丽,等.不同产地黄芩药材中主要药效成分含量变化规律研究[J].天津中医药大学学报,2020,39(3):6. [17] 郑亚威,唐蜀华.唐蜀华治疗高血压病经验撷粹[J].江苏中医药,2019,51(4):3. [18] 李科,刘彦娜,蒋玲.郑州市原发性高血压患者用药依从性及其影响因素分析[J].华南预防医学,2021,47(4):4.
2023, Vol. 43 
